Skip to Content
Merck
All Photos(2)

Documents

Safety Information

GF88601531

Gadolinium

rod, 100mm, diameter 3.0mm, cast, 99%

Synonym(s):

Gadolinium, GD007905

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
Gd
CAS Number:
Molecular Weight:
157.25
MDL number:
UNSPSC Code:
12141605
PubChem Substance ID:
NACRES:
NA.23

Assay

≥99%

form

rod

manufacturer/tradename

Goodfellow 886-015-31

resistivity

126 μΩ-cm, 20°C

bp

3273 °C (lit.)

mp

1313 °C (lit.)

density

7.886 g/mL at 25 °C (lit.)

SMILES string

[Gd]

InChI

1S/Gd

InChI key

UIWYJDYFSGRHKR-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Pictograms

Flame

Signal Word

Warning

Hazard Statements

Hazard Classifications

Water-react 3

Storage Class Code

4.3 - Hazardous materials which set free flammable gases upon contact with water

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

GF88601531-1EA:


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Brigit den Adel et al.
Atherosclerosis, 225(2), 274-280 (2012-08-14)
MRI using targeted contrast agents (CA) has emerged as a promising technique to study atherothrombotic disease in vivo. Particularly, the use of targeted Gd and lipid-based nanoparticles has enabled detailed in vivo imaging of various molecular markers of atherosclerotic plaque
Kanae Kawai Miyake et al.
AJR. American journal of roentgenology, 203(2), 272-279 (2014-07-24)
The purpose of this study was to assess the diagnostic value of (18)F-FDG PET/CT and MRI in predicting the clinicopathologic subtypes of breast cancer. The cases of 89 patients with mass-type invasive breast cancer who underwent FDG PET/CT and MRI
J T Heverhagen et al.
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 186(7), 661-669 (2014-01-31)
Nephrogenic systemic fibrosis (NSF) is a serious, sometimes fatal disease. Findings in recent years have shown that a causal association between gadolinium containing contrast media and NSF is most likely. Therefore, the regulatory authorities have issued guidelines on the use
Anders Bruun Mathiasen et al.
European heart journal, 36(27), 1744-1753 (2015-05-01)
Regenerative treatment with mesenchymal stromal cells (MSCs) has been promising in patients with ischaemic heart failure but needs confirmation in larger randomized trials. We aimed to study effects of intra-myocardial autologous bone marrow-derived MSC treatment in patients with severe ischaemic
Stephanie Nougaret et al.
Radiology, 276(3), 797-808 (2015-05-01)
To investigate magnetic resonance (MR) volumetry of endometrial tumors and its association with deep myometrial invasion, tumor grade, and lymphovascular invasion and to assess the value of apparent diffusion coefficient (ADC) histographic analysis of the whole tumor volume for prediction

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service